Small-Scale Compressed Air Energy Storage Application for Renewable Energy Integration in a Listed Building

In the European Union (EU), where architectural heritage is significant, enhancing the energy performance of historical buildings is of great interest. Constraints such as the lack of space, especially within the historical centers and architectural peculiarities, make the application of technologies for renewable energy production and storage a challenging issue. This study presents a prototype system consisting of using the renewable energy from a photovoltaic (PV) array to compress air for a later expansion to produce electricity when needed. The PV-integrated small-scale compressed air energy storage system is designed to address the architectural constraints. It is located in the unoccupied basement of the building. An energy analysis was carried out for assessing the performance of the proposed system. The novelty of this study is to introduce experimental data of a CAES (compressed air energy storage) prototype that is suitable for dwelling applications as well as integration accounting for architectural constraints. The simulation, which was carried out for an average summer day, shows that the compression phase absorbs 32% of the PV energy excess in a vessel of 1.7 m(3), and the expansion phase covers 21.9% of the dwelling energy demand. The electrical efficiency of a daily cycle is equal to 11.6%. If air is compressed at 225 bar instead of 30 bar, 96.0% of PV energy excess is stored in a volume of 0.25 m3, with a production of 1.273 kWh, which is 26.0% of the demand

Experimental investigation on CO2methanation process for solar energy storage compared to CO2-based methanol synthesis

The utilization of the captured CO2 as a carbon source for the production of energy storage media offers a technological solution for overcoming crucial issues in current energy systems. Solar energy production generally does not match with energy demand because of its intermittent and non-programmable nature, entailing the adoption of storage technologies. Hydrogen constitutes a chemical storage for renewable electricity if it is produced by water electrolysis and is also the key reactant for CO2 methanation (Sabatier reaction). The utilization of CO2 as a feedstock for producing methane contributes to alleviate global climate changes and sequestration related problems. The produced methane is a carbon neutral gas that fits into existing infrastructure and allows issues related to the aforementioned intermittency and non-programmability of solar energy to be overcome. In this paper, an experimental apparatus, composed of an electrolyzer and a tubular fixed bed reactor, is built and used to produce methane via Sabatier reaction. The objective of the experimental campaign is the evaluation of the process performance and a comparison with other CO2 valorization paths such as methanol production. The investigated pressure range was 2–20 bar, obtaining a methane volume fraction in outlet gaseous mixture of 64.75% at 8 bar and 97.24% at 20 bar, with conversion efficiencies of, respectively, 84.64% and 99.06%. The methanol and methane processes were compared on the basis of an energy parameter defined as the spent energy/stored energy. It is higher for the methanol process (0.45), with respect to the methane production process (0.41–0.43), which has a higher energy storage capability

3-hexen-1-ol isomers in Müller-Thurgau wines: A ''varietal'' characteristic affected by must sulfiting time

Research NoteMust sulfiting time can be responsible for differences in the (3E)/(3Z)-hexen-1-ol ratio of wines produced on a semi-industrial and industrial scale. However, as the (3E) isomer is normally higher than the (32) isomer, the ratio could be used, with some caution, as a contributing parameter to verifying the varietal origin of some wines, in particular of Müller-Thurgau. After hexanol, (3E)-hexen-1-ol seems to be the main Cb-alcohol in Müller-Thurgau wines from Trentino (Italy)

An Innovative Configuration for CO2 Capture by High Temperature Fuel Cells

Many technological solutions have been proposed for CO 2 capture in the last few years. Most of them are characterized by high costs in terms of energy consumption and, consequently, higher fossil fuel use and higher economic costs. High temperature fuel cells are technological solutions currently developed for energy production with low environmental impact. In CIRIAF—University of Perugia labs, cylindrical geometry, small-sized molten carbonate fuel cell (MCFC) prototypes were built and tested with good energy production and lifetime performances. In the present work, an innovative application for MCFCs is proposed, and an innovative configuration for CO 2 capture/separation is investigated. The plant scheme is based on a reformer and a cylindrical MCFC. MCFCs are the most suitable solutions, because CO 2 is used in their operating cycle. An analysis in terms of energy consumption/kgCO 2 captured is made by coupling the proposed configuration with a gas turbine plant. The proposed configuration is characterized by a theoretical energy consumption of about 500 kJ/kgCO 2 , which is quite lower than actual sequestration technologies. An experimental campaign will be scheduled to verify the theoretical findings

Effectiveness of chest physiotherapy and pulmonary rehabilitation in patients with non-cystic fibrosis bronchiectasis: a narrative review.

Respiratory physiotherapy and rehabilitation are important therapeutic options in non-cystic fibrosis bronchiectasis (NCFB). The aims of this review of clinical trials were to evaluate the safety and the effects on physiologic and clinical outcomes of airway clearance techniques (ACTs) and rehabilitation in NCFB patients, in comparison to usual care. The search was performed on March 2018 by using PubMed and PeDro databases. 33 studies were selected. The use of ACTs for NCFB were effective in increasing sputum volume although no benefit in quality of life (QoL) or pulmonary exacerbations were observed. There were no differences in effectiveness between the several techniques used. Humidification and saline inhalation were able to aid airway clearance. Hypertonic solution (HS) was more effective than isotonic solutions (IS) in improving expectoration and sputum viscosity. Pulmonary rehabilitation (PR) was found to be associated with short term benefits in exercise capacity, dyspnea and fatigue. Exercise training seems to improve quality of life and lower exacerbation rate, but long-term data are not available. Further studies are necessary to identify the most feasible long-term outcomes such as QoL and exacerbation rate

The effect of composition on structural, thermal, redox and bioactive properties of Ce-containing glasses

The effect of phosphate on the ability of Ce-containing bioactive glasses to inhibit oxidative stress was studied on compositions based on Hench (46.2%SiO224.3%Na2O26.9ÊO2.6P2O5, mol%) and Kokubo (50.0%SiO225.0%Na2O25.0ÊO) glasses. In particular, the reduction of catalase mimetic activity of Ce-containing glasses due to the presence: i) of P2O5 in the glass compositions, and ii) of phosphate groups in the solution employed for catalase mimetic activity tests was explained and rationalized by combining SEM, XPS, XRD, DTA, FT-IR and UV-vis experiments with Molecular Dynamics simulations.The results suggest that the Ce ions play a different structural role in the two series of glasses. In particular, in phosphate free glasses Ce is coordinated by non-bridging oxygens (NBOs) originated from the disruption of the silicate network, whereas in phosphate containing glasses the NBOs around Ce ions belong to orthophosphate groups. The latter groups stabilize the Ce3+ species subtracting them from the interconversion process between Ce3+ and Ce4+, which is of fundamental importance for the exhibition of the catalase mimetic activity

Identidad y Memoria: Los Adultos Mayores cuentan la historia del ex Mercado Abasto de Avellaneda

El proyecto tiene como objetivo generar un aporte comunicacional y social con doble sentido: por un lado lograr la recuperación histórica del Ex Mercado de Abasto de la Ciudad de Avellaneda y su posterior desarrollo como Universidad Nacional, y por otro lado, revalorizar la voz de los adultos mayores y su rol activo en la sociedad actual. A través de los testimonios de estos actores sociales, fieles protagonistas del funcionamiento de aquel antiguo centro comercial, se pretende lograr un registro de historias de vida en formato escrito, fotográfico y audiovisual, que den cuentan de la reconstrucción histórica del lugar. A su vez, el trabajo se plantea como una herramienta de generación/fortalecimiento de lazos sociales comunitarios, vínculos que se entretejen sobre la base de identidades, pertenencias y memoria. El proceso de trabajo se basa en el trabajo  conjunto adultos mayores – jóvenes, fundado en un aprendizaje mutuo e intercambio intergeneracional. De esta manera, no sólo se logra revalorizar un lugar histórico, sino que también se realiza un aporte favorable para retraer la distancia generacional existente en el país entre dichos actores sociales. El presente proyecto se encuentra todavía en proceso y tiene lugar en la Universidad Nacional de Avellaneda a través de encuentros de reflexión-memoria bajo la modalidad de taller, donde los estudiantes empiezan a delinear sus  primeras prácticas pre profesionales y los adultos mayores son participantes activos de las mismas. Las producciones finales relatarán cómo se vivía cuando el predio pertenecía al Mercado de Abasto y empezarán, además, a contar la historia de la naciente Universidad Nacional de Avellaneda

JLB: a flexible and effective device in critical patients. Review of clinical cases

JLB catheter (Deltamed Inc) is an alternative way to manage difficult venous access; it is placed under US-guidance in large bore veins, with an easy-sterile approach. Internal jugular vein (IJV) is the first choice for cannulation, followed by subclavian or deep upper-arm veins. The catheter is available in different lengths and gauges, it allows high flow rates and can be left in place up to 30 days. From June 2015 to March 2017, JLB has been positioned in 409 patients: in 354 as primary access in IJV, brachial or subclavian vein; in 55 cases JLB became an introducing line for the Seldinger guidewire and further CVC positioning. All clinical cases were reviewed selecting those with greater clinical relevance. We report 8 cases in which JLB resulted determinant for the patient treatment: a 16 years old obese girl born with perinatal distress, a 78 years old obese woman with hemorrhagic shock caused by gastrointestinal bleeding, a 40 years old man with severe hypokalemia, a 30 years old man with severe sepsis, a 40 years old man with Becker’s muscular dystrophy and severe sepsis, a 40 years old man with multiple myeloma who had to carry out cycles of chemotherapy, a 76 years old man with CMV pancolitis and myelofibrosis who needed parenteral nutrition, antiviral therapy and frequent blood and platelets transfusion. Moreover, it has been useful in elderly patients who needed to carry out palliative care for seniority or cancer lasting up to 30 days . In our experience the JLB catheter is safe, easy to place, quick and cost –effective. It is a valid solution either in unstable patients requiring an immediate access in emergency and stable patients with difficult venous access, in which invasive devices can be considered an over-treatment

Risk of progression in chronic phase-chronic myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation: Final analysis of the TFR-PRO study

Disease progression to accelerated/blast phase (AP/BP) in patients with chronic phase chronic myeloid leukemia (CP-CML) after treatment discontinuation (TD) has never been systematically reported in clinical trials. However, recent reports of several such cases has raised concern. To estimate the risk of AP/BP among TD-eligible patients, we conducted TFR-PRO, a cohort retro-prospective study: 870 CP-CML patients eligible for TD formed a discontinuation cohort (505 patients) and a reference one (365 patients). The primary objective was the time adjusted rate (TAR) of progression in relation to TD. Secondary endpoints included the TAR of molecular relapse, that is, loss of major molecular response (MMR). With a median follow up of 5.5 years and 5188.2 person-years available, no events occurred in the TD cohort. One event of progression was registered 55 months after the end of TD, when the patient was contributing to the reference cohort. The TAR of progression was 0.019/100 person-years (95% CI [0.003-0.138]) in the overall group; 0.0 (95% CI [0-0.163]) in the discontinuation cohort; and 0.030 (95% CI [0.004-0.215]) in the reference cohort. These differences are not statistically significant. Molecular relapses occurred in 172/505 (34.1%) patients after TD, and in 64/365 (17.5%) patients in the reference cohort, p < .0001. Similar rates were observed in TD patients in first, second or third line of treatment. CML progression in patients eligible for TD is rare and not related to TD. Fears about the risk of disease progression among patients attempting TD should be dissipated